These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30016493)

  • 1. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
    Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
    QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin.
    Wang L; Wang C; Tao Z; Zhu W; Su Y; Choi WS
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166695. PubMed ID: 36958712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages.
    Prieto-Lafuente L; Gregory WF; Allen JE; Maizels RM
    J Leukoc Biol; 2009 May; 85(5):844-54. PubMed ID: 19179453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.
    Yaddanapudi K; Putty K; Rendon BE; Lamont GJ; Faughn JD; Satoskar A; Lasnik A; Eaton JW; Mitchell RA
    J Immunol; 2013 Mar; 190(6):2984-93. PubMed ID: 23390297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
    Safi W; Kraus A; Grampp S; Schödel J; Buchholz B
    J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of macrophage migration inhibitory factor in cartilage tissue engineering.
    Fujihara Y; Hikita A; Takato T; Hoshi K
    J Cell Physiol; 2018 Feb; 233(2):1490-1499. PubMed ID: 28574571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
    Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
    Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis.
    Damle SR; Martin RK; Cross JV; Conrad DH
    Mucosal Immunol; 2017 Jan; 10(1):205-214. PubMed ID: 27049059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
    Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
    Kindt N; Preillon J; Kaltner H; Gabius HJ; Chevalier D; Rodriguez A; Johnson BD; Megalizzi V; Decaestecker C; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2013 May; 139(5):727-37. PubMed ID: 23354841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinoma.
    Ryan N; Lamenza F; Shrestha S; Upadhaya P; Springer A; Jordanides P; Pracha H; Roth P; Kumar R; Wang Y; Vilgelm AE; Satoskar A; Oghumu S
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167345. PubMed ID: 38992847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
    Wang Z; Wei M; Wang M; Chen L; Liu H; Ren Y; Shi K; Jiang H
    Inflammation; 2014 Dec; 37(6):2020-9. PubMed ID: 24958012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
    Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
    Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
    Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
    Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
    Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
    Zhang Z; Zhang R; Li L; Zhu L; Gao S; Lu Q; Gu Y; Zhang Y; Yang H; Hou T; Zhen X; Zheng LT
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):149-157. PubMed ID: 29447014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
    Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
    Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
    Zeng J; Quan J; Xia X
    Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived macrophage migration inhibitory factor mediates renal injury in anti-glomerular basement membrane glomerulonephritis.
    Yang H; Li J; Huang XR; Bucala R; Xu A; Lan HY
    Front Immunol; 2024; 15():1361343. PubMed ID: 38846956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.